Article 5
1. Member States shall immediately inform the Commission of the results of the analytical tests if those tests reveal the presence of residues of any pharmacologically active substance: (a) classified in accordance with Article 14(2)(a), (b) or (c) of Regulation (EC) No 470/2009 at a level exceeding the maximum residue limit established pursuant to that Regulation; or (b) not classified in accordance with Article 14(2)(a), (b) or (c) of Regulation (EC) No 470/2009; however, the Member State concerned is not required to immediately inform the Commission of the results of such tests where the level of residues is lower than: (i) the reference point for action established for that substance pursuant to Regulation (EC) No 470/2009; or (ii) the minimum required performance limit established for that substance pursuant to Decision 2002/657/EC. The results of those analytical tests shall be notified to the Commission under the rapid alert system established pursuant to Article 50 of Regulation (EC) No 178/2002. 2. Every three months Member States shall submit to the Commission a report on all the results of the analytical tests carried out on the consignments in the previous three months. The first report shall be submitted to the Commission by 1 October 2010.